営業外費用計、Accumulated Depreciation Buildings And Structures、Lease Assets NetPPE他3件
- 【期間】
| 年度 | 営業外費用計 | Accumulated Depreciation Buildings And Structures | Lease Assets NetPPE | 全事業営業利益又は全事業営業損失（△） - 医薬品 | Other Capital Surplus | OtherEI |
|---|
| 2009/12 | 262百万 | - | - | - | - | - |
| 2010/12 | 236百万
-9.9% | - | - | - | - | - |
| 2011/12 | 142百万
-39.8% | - | - | - | - | - |
| 2012/12 | 42百万
-70.4% | - | - | - | - | - |
| 2013/12 | 40百万
-4.8% | - | - | 113億 | - | - |
| 2014/12 | 28百万
-30% | - | - | 83.1億
-26.4% | - | - |
| 2015/12 | 28百万
±0% | - | - | - | - | - |
| 2016/12 | 105百万
+275% | - | - | - | - | - |
| 2017/12 | 77百万
-26.7% | - | - | - | - | - |
| 2018/12 | 396百万
+414.3% | - | - | - | - | - |
| 2019/12 | 60百万
-84.8% | - | - | - | - | - |
| 2020/12 | 55百万
-8.3% | - | - | - | - | - |
| 2021/12 | 101百万
+83.6% | - | - | - | - | - |
| 2022/12 | 52百万
-48.5% | - | - | - | - | - |
| 2023/12 | 131百万
+151.9% | - | - | - | - | - |
